Managed Care Considerations on Facilitating the Timely Diagnosis and Evidence-Based Treatment of von Willebrand Disease (VWD): Part II
Part II: Optimizing Clinical and Economic Outcomes in the Management of VWD, featuring Dr. Maria Lopes, former Chief Medical Officer, Magellan